# Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study

> **NCT00256815** · PHASE1,PHASE2 · COMPLETED · sponsor: **Clinical Oncology Research Associates** · enrollment: 35 (—)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** chemotherapy
- **PROCEDURE:** Radiation

## Key facts

- **NCT ID:** NCT00256815
- **Lead sponsor:** Clinical Oncology Research Associates
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 35 (—)
- **Last updated:** 2014-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00256815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00256815, "Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00256815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*